This case study assesses the need for anticoagulation and the drugs of choice for prophylaxis against cerebrovascular accidents (strokes) in patients with previous CVAs of different origins.
Nancy L. Shapiro, Pharm.D., BCPSAimee Chevalier, Pharm.D.
Clinical Pharmacists, Antithrombosis Clinic
Clinical Assistant Professor, Dept. of Pharmacy Practice
University of Illinois at Chicago College of Pharmacy